UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7679) 7679
Book Chapter (66) 66
Newsletter (45) 45
Newspaper Article (33) 33
Magazine Article (19) 19
Conference Proceeding (4) 4
Dissertation (4) 4
Book / eBook (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (6088) 6088
humans (5836) 5836
life sciences & biomedicine (5620) 5620
male (3430) 3430
reverse transcriptase polymerase chain reaction (3288) 3288
female (3134) 3134
hiv infections - drug therapy (2555) 2555
animals (2282) 2282
adult (2179) 2179
reverse transcriptase inhibitors - adverse effects (2067) 2067
reverse transcriptase inhibitors - therapeutic use (1870) 1870
middle aged (1652) 1652
infectious diseases (1382) 1382
anti-hiv agents - adverse effects (1295) 1295
blotting, western (1167) 1167
anti-hiv agents - therapeutic use (1160) 1160
mice (1142) 1142
hiv (1113) 1113
pharmacology & pharmacy (1040) 1040
immunology (1003) 1003
gene expression (997) 997
drug therapy, combination (977) 977
aids/hiv (918) 918
reverse transcriptase inhibitors - administration & dosage (901) 901
oncology (846) 846
research (810) 810
treatment outcome (785) 785
drug therapy (748) 748
rna, messenger - genetics (739) 739
aged (704) 704
analysis (697) 697
virology (690) 690
rats (679) 679
health aspects (647) 647
antiviral agents (644) 644
human immunodeficiency virus--hiv (610) 610
hiv infections - virology (598) 598
abridged index medicus (589) 589
immunohistochemistry (579) 579
anti-hiv agents - administration & dosage (566) 566
cells, cultured (552) 552
risk factors (552) 552
hiv infection (545) 545
research article (535) 535
viral load (535) 535
hiv-1 - drug effects (533) 533
antiretroviral drugs (526) 526
cd4 lymphocyte count (519) 519
hiv protease inhibitors - adverse effects (507) 507
proteins (504) 504
hiv protease inhibitors - therapeutic use (500) 500
biochemistry & molecular biology (484) 484
cell biology (484) 484
apoptosis (481) 481
rna, messenger - metabolism (469) 469
medicine (468) 468
science & technology - other topics (460) 460
highly active antiretroviral therapy (456) 456
cell line, tumor (454) 454
adolescent (451) 451
multidisciplinary sciences (450) 450
time factors (448) 448
care and treatment (447) 447
real-time polymerase chain reaction (445) 445
antiretroviral therapy (443) 443
hiv infections - complications (441) 441
lamivudine - therapeutic use (435) 435
reverse transcriptase inhibitors (433) 433
pregnancy (428) 428
genetic aspects (423) 423
hiv-1 (423) 423
tenofovir (423) 423
physiological aspects (419) 419
protease inhibitors (412) 412
microbiology (408) 408
dose-response relationship, drug (403) 403
cancer (401) 401
adenine - analogs & derivatives (396) 396
aids (385) 385
mice, inbred c57bl (383) 383
mutation (382) 382
rna (381) 381
reverse transcriptase inhibitors - pharmacology (376) 376
science (374) 374
medicine & public health (372) 372
antiretroviral therapy, highly active - adverse effects (355) 355
cell line (344) 344
antiretroviral therapy, highly active (343) 343
polymerase chain reaction (342) 342
human immunodeficiency virus (339) 339
young adult (339) 339
gene expression profiling (337) 337
reverse transcriptase inhibitors - pharmacokinetics (336) 336
drug interactions (333) 333
rodents (333) 333
flow cytometry (331) 331
apoptosis - drug effects (328) 328
lamivudine (316) 316
disease models, animal (312) 312
oligonucleotide array sequence analysis (311) 311
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7647) 7647
Spanish (79) 79
German (59) 59
French (40) 40
Japanese (32) 32
Portuguese (18) 18
Chinese (13) 13
Italian (10) 10
Dutch (9) 9
Polish (5) 5
Russian (4) 4
Turkish (3) 3
Norwegian (2) 2
Czech (1) 1
Danish (1) 1
Hungarian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of infectious diseases, ISSN 0022-1899, 4/2013, Volume 207, Issue 7, pp. 1157 - 1165
...) are at increased risk of age-related complications. We hypothesized that nucleos(t)ide reverse transcriptase inhibitors (NRTI... 
T lymphocytes | HIV/AIDS | Telomeres | Antiretrovirals | HIV | Final causes | Cell lines | Nucleosides | Reverse transcriptase inhibitors | Carts | Disease risks | telomerase | aging | HIV infection | antiretroviral therapy | telomere | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Humans | Middle Aged | Aging - drug effects | Antiretroviral Therapy, Highly Active - adverse effects | Male | Telomere - drug effects | Case-Control Studies | Lamivudine - adverse effects | Reverse Transcriptase Inhibitors - adverse effects | Tenofovir | Young Adult | Telomere Shortening | Adenine - adverse effects | HIV Infections - pathology | Time Factors | Polymerase Chain Reaction | Adult | Deoxycytidine - adverse effects | Female | Telomerase - metabolism | Dideoxynucleosides - adverse effects | Emtricitabine | Adenine - analogs & derivatives | Leukocytes, Mononuclear - drug effects | Zidovudine - adverse effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Risk Factors | Cells, Cultured | Organophosphonates - adverse effects | HIV - pathogenicity | Enzyme Activation - drug effects | Regression Analysis | Telomere - enzymology | HIV Infections - drug therapy | Leukocytes, Mononuclear - enzymology | Telomerase - antagonists & inhibitors | Deoxycytidine - analogs & derivatives | Complications and side effects | Demographic aspects | Physiological aspects | Aging | Research | Telomerase | Index Medicus | Abridged Index Medicus
Journal Article
by Hakim, James G and Thompson, Jennifer and Kityo, Cissy and Hoppe, Anne and Kambugu, Andrew and van Oosterhout, Joep J and Lugemwa, Abbas and Siika, Abraham and Mwebaze, Raymond and Mweemba, Aggrey and Abongomera, George and Thomason, Margaret J and Easterbrook, Philippa and Mugyenyi, Peter and Walker, A Sarah and Paton, Nicholas I and Agweng, E and Awio, P and Bakeinyaga, G and Isabirye, C and Kabuga, U and Kasuswa, S and Katuramu, M and Kiweewa, F and Kyomugisha, H and Lutalo, E and Mulima, D and Musana, H and Musitwa, G and Musiime, V and Ndigendawan, M and Namata, H and Nkalubo, J and Labejja, P Ocitti and Okello, P and Olal, P and Pimundu, G and Segonga, P and Ssali, F and Tamale, Z and Tumukunde, D and Namala, W and Byaruhanga, R and Kayiwa, J and Tukamushaba, J and Abunyang, S and Eram, D and Denis, O and Lwalanda, R and Mugarura, L and Namusanje, J and Nankya, I and Ndashimye, E and Nabulime, E and Senfuma, O and Bihabwa, G and Buluma, E and Elbireer, A and Kamya, D and Katwere, M and Kiggundu, R and Komujuni, C and Laker, E and Lubwama, E and Mambule, I and Matovu, J and Nakajubi, A and Nakku, J and Nalumenya, R and Namuyimbwa, L and Semitala, F and Wandera, B and Wanyama, J and Mugerwa, H and Ninsiima, E and Ssenkindu, T and Mwebe, S and Atwine, L and William, H and Katemba, C and Acaku, M and Ssebutinde, P and Kitizo, H and Kukundakwe, J and Naluguza, M and Ssegawa, K and Namayanja and Nsibuka, F and Tuhirirwe, P and Fortunate, M and Acen, J and Achidri, J and Amone, A and Chamai, M and Ditai, J and Kemigisa, M and Kiconco, M and Matama, C and Mbanza, D and Nambaziira, F and ... and Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team and Europe Africa Res Network
The Lancet infectious diseases, ISSN 1473-3099, 01/2018, Volume 18, Issue 1, pp. 47 - 57
Journal Article
Journal of acquired immune deficiency syndromes (1999), ISSN 1525-4135, 2015, Volume 68, Issue 5, pp. 568 - 577
Journal Article
The Journal of infectious diseases, ISSN 1537-6613, 10/2015, Volume 212, Issue 8, pp. 1241 - 1249
Journal Article
HIV medicine, ISSN 1464-2662, 01/2018, Volume 19, Issue 1, pp. 18 - 32
Antiretroviral (ARV) therapy, comprising a backbone of two nucleos(t)ide reverse transcriptase inhibitors (NRTIs... 
HIV | nucleoside reverse transcriptase inhibitor‐reducing strategies | antiretroviral backbone | nucleoside reverse transcriptase inhibitor-reducing strategies | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Nucleosides - administration & dosage | Anti-HIV Agents - adverse effects | Humans | Antiretroviral Therapy, Highly Active - adverse effects | Treatment Outcome | Nucleosides - adverse effects | Reverse Transcriptase Inhibitors - administration & dosage | Drug Utilization | Randomized Controlled Trials as Topic | Anti-HIV Agents - administration & dosage | Reverse Transcriptase Inhibitors - adverse effects | HIV Infections - drug therapy | Antiretroviral Therapy, Highly Active - methods | Protease inhibitors | AIDS treatment | Proteases | Analysis | Nucleosides | DNA polymerases | Bones | Reverse transcriptase inhibitors | Diagnosis | HIV (Viruses) | Drug therapy | Density | Failure rates | Therapy | Salts | Renal function | RNA-directed DNA polymerase | Toxicity | Ritonavir | Central nervous system | Clinical trials | Lipids | Tenofovir | Randomization | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Safety | Integrase | Medical research | Antiretroviral drugs | Atlas | Effectiveness | Life expectancy | Lamivudine | Life span | Bone mineral density | Adults | Mutation | Kidney transplantation | Index Medicus
Journal Article
Journal of pharmaceutical sciences, ISSN 0022-3549, 10/2015, Volume 104, Issue 10, pp. 3426 - 3439
Journal Article